Company intelligence / Profile preview

Bio-Scaffold International

Simei, Singapore, Singaporesg.linkedin.com ↗

Ownership: Private
Employees: ~5
Development stage: Commercial

Overview

Bio-Scaffold International has developed a proprietary 3D printing platform to manufacture metallic and polymeric scaffolds for tissue engineering. Their technology is validated in dental applications—specifically alveolar bone preservation post-extraction—with a completed clinical trial demonstrating radiographic evidence of bone regeneration using PLGA bioscaffolds. The company aims to expand into other areas such as orthopedics and cosmetology

Therapeutic areas: Other
Modalities: DeviceHydrogel-based drug delivery therapy (potentially)Polymer-based scaffoldMetal-based scaffold
Industry: Implantable Medical Devices

Partnerships

Stelis Biopharma (research collaboration)

Beyond the preview

Go deeper on Bio-Scaffold International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bio-Scaffold International.

Explore the full profile